Cargando…

Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina

BACKGROUND AND PURPOSE: Because of the high prevalence, diabetes is considered a global health threat. Hence, the need for effective, cheap, and comfortable therapies are highly felt. In previous study, a novel oligosaccharide with strong anti-diabetic activity in the crude extract of Rosa canina fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahrami, Gholamreza, Miraghaee, Seyed Shahram, Mohammadi, Bahar, Bahrami, Mohammad Taher, Taheripak, Gholamreza, Keshavarzi, Samira, Babaei, Atefeh, Sajadimajd, Soraya, Hatami, Razieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053289/
https://www.ncbi.nlm.nih.gov/pubmed/32180815
http://dx.doi.org/10.4103/1735-5362.278713
_version_ 1783503011703685120
author Bahrami, Gholamreza
Miraghaee, Seyed Shahram
Mohammadi, Bahar
Bahrami, Mohammad Taher
Taheripak, Gholamreza
Keshavarzi, Samira
Babaei, Atefeh
Sajadimajd, Soraya
Hatami, Razieh
author_facet Bahrami, Gholamreza
Miraghaee, Seyed Shahram
Mohammadi, Bahar
Bahrami, Mohammad Taher
Taheripak, Gholamreza
Keshavarzi, Samira
Babaei, Atefeh
Sajadimajd, Soraya
Hatami, Razieh
author_sort Bahrami, Gholamreza
collection PubMed
description BACKGROUND AND PURPOSE: Because of the high prevalence, diabetes is considered a global health threat. Hence, the need for effective, cheap, and comfortable therapies are highly felt. In previous study, a novel oligosaccharide with strong anti-diabetic activity in the crude extract of Rosa canina fruits, from the rosacea family, was identified. The present study was designed to ensure its efficacy using in vivo and in vitro studies. EXPERIMENTAL APPROACH: Crude extract and its purified oligosaccharide were prepared from corresponding herb. Adult male Wistar rats were randomly divided into four groups of 10 each, as follows: group 1, healthy control rats given only sterile normal saline; group 2, diabetic control rats received sterile normal saline; group 3, diabetic rats treated with crude extract of Rosa canina (40% w/v) by oral gavage for 8 weeks; group 4, diabetic rats treated with purified oligosaccharide of Rosa canina (2 mg/kg) by oral gavage for 8 weeks. After treatment, body weight, fasting blood glucose, serum insulin levels and islet beta-cell repair and proliferation were investigated. The possible cytoprotective action of oligosaccharide was evaluated in vitro. The effect of oligosaccharide on apoptosis and insulin secretion in cell culture media were examined. Real-time PCR was used to determine the expression level of some glucose metabolism-related regulator genes. FINDINGS / RESULTS: In the animal model of diabetes, the insulin levels were increased significantly due to the regeneration of beta-cells in the islands of langerhans by the purified oligosaccharide. In vitro cell apoptosis examination showed that high concentration of oligosaccharide increased cell death, while at low concentration protected cells from streptozotocin-induced apoptosis. Molecular study showed that the expression of Ins1 and Pdx1 insulin production genes were increased, leading to increased expression of insulin-dependent genes such as Gck and Ptp1b. On the other hand, the expression of the Slc2a2 gene, which is related to the glucose transporter 2, was significantly reduced due to insulin concentrations. CONCLUSION AND IMPLICATIONS: The purified oligosaccharide from Rosa canina was a reliable anti-diabetic agent, which acted by increasing insulin production in beta-cells of the islands of Langerhans.
format Online
Article
Text
id pubmed-7053289
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-70532892020-03-16 Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina Bahrami, Gholamreza Miraghaee, Seyed Shahram Mohammadi, Bahar Bahrami, Mohammad Taher Taheripak, Gholamreza Keshavarzi, Samira Babaei, Atefeh Sajadimajd, Soraya Hatami, Razieh Res Pharm Sci Original Article BACKGROUND AND PURPOSE: Because of the high prevalence, diabetes is considered a global health threat. Hence, the need for effective, cheap, and comfortable therapies are highly felt. In previous study, a novel oligosaccharide with strong anti-diabetic activity in the crude extract of Rosa canina fruits, from the rosacea family, was identified. The present study was designed to ensure its efficacy using in vivo and in vitro studies. EXPERIMENTAL APPROACH: Crude extract and its purified oligosaccharide were prepared from corresponding herb. Adult male Wistar rats were randomly divided into four groups of 10 each, as follows: group 1, healthy control rats given only sterile normal saline; group 2, diabetic control rats received sterile normal saline; group 3, diabetic rats treated with crude extract of Rosa canina (40% w/v) by oral gavage for 8 weeks; group 4, diabetic rats treated with purified oligosaccharide of Rosa canina (2 mg/kg) by oral gavage for 8 weeks. After treatment, body weight, fasting blood glucose, serum insulin levels and islet beta-cell repair and proliferation were investigated. The possible cytoprotective action of oligosaccharide was evaluated in vitro. The effect of oligosaccharide on apoptosis and insulin secretion in cell culture media were examined. Real-time PCR was used to determine the expression level of some glucose metabolism-related regulator genes. FINDINGS / RESULTS: In the animal model of diabetes, the insulin levels were increased significantly due to the regeneration of beta-cells in the islands of langerhans by the purified oligosaccharide. In vitro cell apoptosis examination showed that high concentration of oligosaccharide increased cell death, while at low concentration protected cells from streptozotocin-induced apoptosis. Molecular study showed that the expression of Ins1 and Pdx1 insulin production genes were increased, leading to increased expression of insulin-dependent genes such as Gck and Ptp1b. On the other hand, the expression of the Slc2a2 gene, which is related to the glucose transporter 2, was significantly reduced due to insulin concentrations. CONCLUSION AND IMPLICATIONS: The purified oligosaccharide from Rosa canina was a reliable anti-diabetic agent, which acted by increasing insulin production in beta-cells of the islands of Langerhans. Wolters Kluwer - Medknow 2020-02-20 /pmc/articles/PMC7053289/ /pubmed/32180815 http://dx.doi.org/10.4103/1735-5362.278713 Text en Copyright: © 2020 Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bahrami, Gholamreza
Miraghaee, Seyed Shahram
Mohammadi, Bahar
Bahrami, Mohammad Taher
Taheripak, Gholamreza
Keshavarzi, Samira
Babaei, Atefeh
Sajadimajd, Soraya
Hatami, Razieh
Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title_full Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title_fullStr Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title_full_unstemmed Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title_short Molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from Rosa canina
title_sort molecular mechanism of the anti-diabetic activity of an identified oligosaccharide from rosa canina
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053289/
https://www.ncbi.nlm.nih.gov/pubmed/32180815
http://dx.doi.org/10.4103/1735-5362.278713
work_keys_str_mv AT bahramigholamreza molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT miraghaeeseyedshahram molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT mohammadibahar molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT bahramimohammadtaher molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT taheripakgholamreza molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT keshavarzisamira molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT babaeiatefeh molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT sajadimajdsoraya molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina
AT hatamirazieh molecularmechanismoftheantidiabeticactivityofanidentifiedoligosaccharidefromrosacanina